He has accumulated a 49% stake in Stallergenes, a European biopharmaceutical firm specializing in the treatment of severe respiratory allergies by allergen immunotherapy, and has made a tender offer for the rest of the shares.

FORBES: Davos: America's Cup Winner Moves On

Participants in immunotherapy studies have reported that they learned not to take their regulated allergen doses before exercising because it causes a faster absorption of proteins and can trigger a reaction, she said.

CNN: 'Exciting' advance reported in peanut allergy therapy